Login
|
New Account
AAAAAA
ITA
ENG
Results:
1-19
|
Table of contents of journal:
Results: 19
Genetic background: Patients
Authors:
Makita, Y Tomino, Y
Citation:
Y. Makita et Y. Tomino, Genetic background: Patients, CONTR NEPHR, 134, 2001, pp. 1-8
Animal models
Authors:
Shike, T Funabiki, K Tomino, Y
Citation:
T. Shike et al., Animal models, CONTR NEPHR, 134, 2001, pp. 9-15
Mesangial cell dysfunction as a pathogenesis of diabetic nephropathy
Authors:
Haneda, M Koya, D Kikkawa, R
Citation:
M. Haneda et al., Mesangial cell dysfunction as a pathogenesis of diabetic nephropathy, CONTR NEPHR, 134, 2001, pp. 16-29
Advanced glycation end products and the pathogenesis of diabetic nephropathy
Authors:
Yamagishi, S Masayoshi, T Makita, Z
Citation:
S. Yamagishi et al., Advanced glycation end products and the pathogenesis of diabetic nephropathy, CONTR NEPHR, 134, 2001, pp. 30-35
Carbonyl stress
Authors:
Suzuki, D Miyata, T Kurokawa, K
Citation:
D. Suzuki et al., Carbonyl stress, CONTR NEPHR, 134, 2001, pp. 36-45
Role of macrophages in the pathogenesis of diabetic nephropathy
Authors:
Shikata, K Makino, H
Citation:
K. Shikata et H. Makino, Role of macrophages in the pathogenesis of diabetic nephropathy, CONTR NEPHR, 134, 2001, pp. 46-54
Lipid abnormality
Authors:
Mune, M Otani, H Kimura, K
Citation:
M. Mune et al., Lipid abnormality, CONTR NEPHR, 134, 2001, pp. 55-62
Impairment of ECM production
Authors:
Horikoshi, S Kanamara, Y Funabiki, K Tomino, Y
Citation:
S. Horikoshi et al., Impairment of ECM production, CONTR NEPHR, 134, 2001, pp. 63-68
Podocyte loss and progression of diabetic nephropathy
Authors:
Shirato, I Hishiki, T Tomino, Y
Citation:
I. Shirato et al., Podocyte loss and progression of diabetic nephropathy, CONTR NEPHR, 134, 2001, pp. 69-73
Efficacy of ACE inhibitor (captopril) on glomerular antioxidant enzyme activity and hypertension in diabetic hypertensive rats
Authors:
Shou, I Fukui, M Tomino, Y
Citation:
I. Shou et al., Efficacy of ACE inhibitor (captopril) on glomerular antioxidant enzyme activity and hypertension in diabetic hypertensive rats, CONTR NEPHR, 134, 2001, pp. 74-78
Classification of type-2 diabetic nephropathy in Japan
Authors:
Tomino, Y
Citation:
Y. Tomino, Classification of type-2 diabetic nephropathy in Japan, CONTR NEPHR, 134, 2001, pp. 79-81
Serum cystatin c
Authors:
Tomino, Y
Citation:
Y. Tomino, Serum cystatin c, CONTR NEPHR, 134, 2001, pp. 82-84
Urinary type-IV collagen
Authors:
Tomino, Y
Citation:
Y. Tomino, Urinary type-IV collagen, CONTR NEPHR, 134, 2001, pp. 85-87
Urinary albumin fragments
Authors:
Yagame, M Sakai, H
Citation:
M. Yagame et H. Sakai, Urinary albumin fragments, CONTR NEPHR, 134, 2001, pp. 88-96
Renal biopsy findings and clinical course
Authors:
Nishi, S Ueno, M Gejyo, F
Citation:
S. Nishi et al., Renal biopsy findings and clinical course, CONTR NEPHR, 134, 2001, pp. 97-105
Blood glucose control
Authors:
Uchino, H Kawamori, R
Citation:
H. Uchino et R. Kawamori, Blood glucose control, CONTR NEPHR, 134, 2001, pp. 106-112
Blood pressure control in diabetic nephropathy
Authors:
Katayama, S
Citation:
S. Katayama, Blood pressure control in diabetic nephropathy, CONTR NEPHR, 134, 2001, pp. 113-119
Dietary protein restriction and nutritional adequacy in diabetic nephropathy
Authors:
Kanauchi, M
Citation:
M. Kanauchi, Dietary protein restriction and nutritional adequacy in diabetic nephropathy, CONTR NEPHR, 134, 2001, pp. 120-126
Future strategy: Gene therapy for diabetic nephropathy
Authors:
Isaka, Y Imai, E
Citation:
Y. Isaka et E. Imai, Future strategy: Gene therapy for diabetic nephropathy, CONTR NEPHR, 134, 2001, pp. 127-132
Risultati:
1-19
|